Literature DB >> 4293798

Some aspects of the pharmacology of metyrapone.

J G Sprunt, M C Browning, D M Hannah.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4293798      PMCID： PMC1901968     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  7 in total

1.  Action of metyrapone on the redox state of free nicotinamide-adenine dinucleotide and on oxygen consumption of perfused rat livers and isolated mitochondria.

Authors:  G F Kahl; S Simon
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

2.  Metabolism of metyrapone by a soluble enzyme system in rat liver.

Authors:  W Dünges; G F Kahl
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

3.  Experiments on the metyrapone reducing microsomal enzyme system.

Authors:  G F Kahl
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

4.  Kinetic experiments on the binding of metyrapone to liver microsomes.

Authors:  K J Netter; G F Kahl; M P Magnussen
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1969

5.  Alteration of the inhibitory effect of metyrapone by reduction to metyrapol during the metabolism of methacetin in vivo in mice.

Authors:  E Maser; W Legrum
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

6.  Adrenal Cushing Syndrome Diagnosed During Pregnancy: Successful Medical Management With Metyrapone.

Authors:  Alescia Azzola; Genevieve Eastabrook; Doreen Matsui; Amanda Berberich; Rommel G Tirona; Daryl Gray; Patricia Gallego; Stan Van Uum
Journal:  J Endocr Soc       Date:  2020-11-05

7.  Effects of the pattern of glucocorticoid replacement on neural processing, emotional reactivity and well-being in healthy male individuals: study protocol for a randomised controlled trial.

Authors:  Konstantinos Kalafatakis; Georgina M Russell; Catherine J Harmer; Marcus R Munafo; Nicky Marchant; Aileen Wilson; Jonathan C W Brooks; Ngoc J Thai; Stuart G Ferguson; Kirsty Stevenson; Claire Durant; Kristin Schmidt; Stafford L Lightman
Journal:  Trials       Date:  2016-01-22       Impact factor: 2.279
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.